Purchase Order 36C25626P0171
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Firm Fixed Price Purchase Order to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company, to provide prosthetic products valued at $15,000.00. The contract has a completion date of November 30, 2024 and was awarded on May 31, 2024. Edwards Lifesciences LLC is a global leader in cardiovascular medical devices and has received numerous prime contract awards from...
- Edwards Lifesciences LLC has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network 22 (VISN 22), a civilian component of the U.S. Department of Veterans Affairs, for prosthetics and implant products. The contract, valued at $34,000 with an ultimate completion date of February 27, 2026, carries no set-aside designation and will be performed in Irvine, California. This award reflects Edwards Lifesciences LLC's ongoing role as a critical supplier of advanced...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $32,500 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 10 for post-implant cardiovascular medical equipment. The contract, issued on December 3, 2025, carries an ultimate completion date of March 3, 2026, with performance to be conducted in Irvine, California. This award does not include a set-aside designation and represents...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 1, a civilian component of the U.S. Department of Veterans Affairs. This contract, awarded on October 28, 2025, with an ultimate completion date of January 27, 2026, covers the procurement of cardiac implants for delivery to the VA facility in...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 22 for prosthetic emergency heart valves. The contract, awarded on November 6, 2025, with performance in Irvine, California, carries a completion date of December 31, 2025. This award represents a non-set-aside procurement through the Department of...
- Edwards Lifesciences LLC has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the U.S. Department of Veterans Affairs. The contract, designated S3U RESILIA, does not utilize a set-aside designation and is scheduled for completion by March 31, 2026. Performance will occur in Dallas, Texas. The award represents a purchase order for specialized cardiovascular medical devices, consistent with Edwards Lifesciences...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order valued at $43,000 by Veterans Integrated Service Network 21 (VISN 21), part of the U.S. Department of Veterans Affairs. The contract, awarded on October 27, 2025, calls for the delivery of surgical implants and is scheduled for completion by November 27, 2025. The place of performance is Irvine, California. This...
- Edwards Lifesciences LLC has been awarded a $16,000 firm fixed-price purchase order by Veterans Integrated Service Network 22, a component of the U.S. Department of Veterans Affairs, for prosthetics emergency heart valve surgical implants. The contract, awarded December 9, 2025, with an ultimate completion date of January 31, 2026, will be performed in Irvine, California. This purchase order represents a tactical procurement to support immediate veteran healthcare needs for advanced...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network 19 (VISN 19), a civilian component of the Department of Veterans Affairs. The contract, designated for post-surgery medical support, was awarded on November 3, 2025, with an ultimate completion date of November 7, 2025. The contract carries no set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network 8 (VISN 8) for heart valve products valued at $34,000. The contract, awarded on October 23, 2025, carries an ultimate completion date of November 30, 2025, with performance taking place in Irvine, California. This award represents a direct procurement with no set-aside...
Edwards Lifesciences LLC was awarded a firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 17, a civilian agency within the Department of Veterans Affairs, for prosthetic devices valued at $34,000. The contract was awarded on November 14, 2025, with an ultimate completion date of May 14, 2026, and will be performed in Houston, Texas. No set-aside designation was utilized for this award. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized as a self-certified small disadvantaged business, is the sole prime contractor on this engagement. Edwards Lifesciences LLC specializes in advanced cardiovascular medical devices, including transcatheter heart valves and surgical implants designed to support the VA's veteran healthcare operations. This purchase order is consistent with the company's primary federal contracting activity, which focuses on supplying specialized cardiac devices to the VA across multiple VISNs through firm fixed-price agreements. The prosthetic devices procured under this contract will support VISN 17's cardiac care capabilities and align with the company's broader role as a critical supplier of innovative cardiovascular technologies to the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 11/14/25 |